Neogen Corp
NEOG6.530USD
+0.170+2.67%
Close 11/11, 16:00（ET）Quotes delayed by 15 min
1.42BMarket Cap
LossP/E TTM
More Details of Neogen Corp Company
Neogen Corporation is engaged in developing, manufacturing and marketing a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. Its Food Safety segment consists primarily of diagnostic test kits and complementary products sold to food producers and processors to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues and general sanitation concerns. The Company’s Animal Safety segment is engaged in the development, manufacture, marketing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services for the worldwide animal safety market.
Neogen Corp Info
Ticker SymbolNEOG
Company nameNeogen Corp
IPO dateAug 23, 1989
CEOMr. Mikhael Nassif
Number of employees2974
Security typeOrdinary Share
Fiscal year-endAug 23
Address620 Lesher Pl
CityLANSING
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code48912
Phone15173729200
Websitehttps://www.neogen.com/
Ticker SymbolNEOG
IPO dateAug 23, 1989
CEOMr. Mikhael Nassif
Company Executives of Neogen Corp
Name
Name/Position
Position
Shareholding
Change
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+28.34%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
81.02K
+16.11%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+29.59%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+107.76%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+178.32%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+184.78%
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
25.86K
+324.61%
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
25.39K
+351.76%
Mr. Avi Pelossof
Mr. Avi Pelossof
Director
Director
19.39K
--
Mr. Bryan Riggsbee
Mr. Bryan Riggsbee
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+28.34%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
81.02K
+16.11%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+29.59%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+107.76%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+178.32%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+184.78%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
325.92M
36.43%
Bacterial & General Sanitation
164.78M
18.42%
Rodenticides, Insecticides & Disinfectants
135.03M
15.09%
Genomics Services
89.25M
9.98%
Natural Toxins, Allergens & Drug Residues
77.06M
8.61%
Other
102.62M
11.47%
By RegionUSD
Name
Revenue
Proportion
International
448.73M
50.16%
Domestic
445.94M
49.84%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
325.92M
36.43%
Bacterial & General Sanitation
164.78M
18.42%
Rodenticides, Insecticides & Disinfectants
135.03M
15.09%
Genomics Services
89.25M
9.98%
Natural Toxins, Allergens & Drug Residues
77.06M
8.61%
Other
102.62M
11.47%
Shareholding Stats
Updated: 8 hours ago
Updated: 8 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
11.01%
ING Bank N.V.
6.47%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Other
57.51%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.68%
The Vanguard Group, Inc.
11.01%
ING Bank N.V.
6.47%
Clarkston Capital Partners, LLC
6.45%
Gates Capital Management, Inc.
5.89%
Other
57.51%
Shareholder Types
Shareholders
Proportion
Investment Advisor
46.88%
Investment Advisor/Hedge Fund
36.51%
Hedge Fund
15.72%
Bank and Trust
6.93%
Research Firm
5.01%
Sovereign Wealth Fund
4.25%
Pension Fund
1.57%
Individual Investor
0.89%
Private Equity
0.29%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
733
254.38M
117.06%
-53.44M
2025Q2
720
240.23M
110.60%
-42.75M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
2023Q2
761
232.20M
107.41%
-2.78M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
27.55M
12.68%
-1.06M
-3.71%
Jun 30, 2025
The Vanguard Group, Inc.
23.53M
10.83%
+27.21K
+0.12%
Jun 30, 2025
Clarkston Capital Partners, LLC
14.01M
6.45%
+7.73M
+123.16%
Jun 30, 2025
Gates Capital Management, Inc.
12.79M
5.89%
+3.64M
+39.72%
Jun 30, 2025
Southpoint Capital Advisors LP
10.00M
4.6%
+10.00M
--
Jun 30, 2025
William Blair Investment Management, LLC
9.40M
4.33%
-4.16M
-30.65%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
9.13M
4.2%
+697.10K
+8.26%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
9.08M
4.18%
-5.73M
-38.70%
Jun 30, 2025
State Street Investment Management (US)
8.59M
3.95%
-18.09K
-0.21%
Jun 30, 2025
View more
Related ETFs
Updated: Thu, Nov 6
Updated: Thu, Nov 6
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.68%
Invesco S&P SmallCap Health Care ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.48%
Federated Hermes MDT Small Cap Core ETF
0.3%
VanEck Agribusiness ETF
0.29%
Inspire Small/Mid Cap ESG ETF
0.23%
Amplify Etho Climate Leadership U.S. ETF
0.19%
Invesco S&P SmallCap 600 Pure Value ETF
0.18%
SPDR S&P 600 Small Cap Value ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.17%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.68%
Invesco S&P SmallCap Health Care ETF
Proportion0.79%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.48%
Federated Hermes MDT Small Cap Core ETF
Proportion0.3%
VanEck Agribusiness ETF
Proportion0.29%
Inspire Small/Mid Cap ESG ETF
Proportion0.23%
Amplify Etho Climate Leadership U.S. ETF
Proportion0.19%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.18%
SPDR S&P 600 Small Cap Value ETF
Proportion0.17%
iShares S&P Small-Cap 600 Value ETF
Proportion0.17%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
May 12, 2021
Split
1→2
Date
Type
Ratio
May 12, 2021
Split
1→2
